Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DASATINIB | 100MG | TABLET | Resolved | 2022-11-20 | 2022-12-17 | 175315 |
APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2022-11-20 | 2023-01-20 | 175318 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-11-20 | 2022-12-23 | 175321 |
APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2022-11-20 | 2023-04-14 | 175324 |
APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2022-11-20 | 2022-12-23 | 175327 |
APO-HYDRALAZINE | 10MG | TABLET TABLET | Resolved | 2022-11-27 | 2022-12-23 | 175889 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-11-27 | 2022-12-23 | 175892 |
APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-27 | 2023-01-06 | 175895 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2022-11-27 | 2023-03-09 | 175898 |
APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-11-27 | 2023-03-16 | 175901 |
APO-AMOXI | 500MG | CAPSULE | Resolved | 2022-11-27 | 2023-01-06 | 175904 |
APO-AMLODIPINE-ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2022-12-02 | 2023-03-02 | 176924 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-02 | 2023-01-26 | 176942 |
TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | TABLET | Resolved | 2022-12-02 | 2023-03-16 | 176945 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-12-05 | 2023-01-06 | 177111 |
APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2022-12-05 | 2023-02-02 | 177115 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2022-12-05 | 2023-03-09 | 177120 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2022-12-05 | 2023-04-06 | 177123 |
APO-DASATINIB | 20MG | TABLET | Resolved | 2022-12-05 | 2023-03-16 | 177126 |
APO-AMOXI | 250MG | CAPSULE | Resolved | 2022-12-05 | 2023-04-14 | 177129 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |